author_facet Aronoff, S C
Jacobs, M R
Johenning, S
Yamabe, S
Aronoff, S C
Jacobs, M R
Johenning, S
Yamabe, S
author Aronoff, S C
Jacobs, M R
Johenning, S
Yamabe, S
spellingShingle Aronoff, S C
Jacobs, M R
Johenning, S
Yamabe, S
Antimicrobial Agents and Chemotherapy
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
Infectious Diseases
Pharmacology (medical)
Pharmacology
author_sort aronoff, s c
spelling Aronoff, S C Jacobs, M R Johenning, S Yamabe, S 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.26.4.580 <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin Antimicrobial Agents and Chemotherapy
doi_str_mv 10.1128/aac.26.4.580
facet_avail Online
Free
finc_class_facet Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Society for Microbiology, 1984
imprint_str_mv American Society for Microbiology, 1984
issn 0066-4804
1098-6596
issn_str_mv 0066-4804
1098-6596
language English
mega_collection American Society for Microbiology (CrossRef)
match_str aronoff1984comparativeactivitiesofthebetalactamaseinhibitorsytr830sodiumclavulanateandsulbactamcombinedwithamoxicillinorampicillin
publishDateSort 1984
publisher American Society for Microbiology
recordtype ai
record_format ai
series Antimicrobial Agents and Chemotherapy
source_id 49
title Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_unstemmed Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_full Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_fullStr Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_full_unstemmed Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_short Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_sort comparative activities of the beta-lactamase inhibitors ytr 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
topic Infectious Diseases
Pharmacology (medical)
Pharmacology
url http://dx.doi.org/10.1128/aac.26.4.580
publishDate 1984
physical 580-582
description <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p>
container_issue 4
container_start_page 580
container_title Antimicrobial Agents and Chemotherapy
container_volume 26
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792336972494143493
geogr_code not assigned
last_indexed 2024-03-01T15:08:54.718Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Comparative+activities+of+the+beta-lactamase+inhibitors+YTR+830%2C+sodium+clavulanate%2C+and+sulbactam+combined+with+amoxicillin+or+ampicillin&rft.date=1984-10-01&genre=article&issn=1098-6596&volume=26&issue=4&spage=580&epage=582&pages=580-582&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Comparative+activities+of+the+beta-lactamase+inhibitors+YTR+830%2C+sodium+clavulanate%2C+and+sulbactam+combined+with+amoxicillin+or+ampicillin&aulast=Yamabe&aufirst=S&rft_id=info%3Adoi%2F10.1128%2Faac.26.4.580&rft.language%5B0%5D=eng
SOLR
_version_ 1792336972494143493
author Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S
author_facet Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S, Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S
author_sort aronoff, s c
container_issue 4
container_start_page 580
container_title Antimicrobial Agents and Chemotherapy
container_volume 26
description <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p>
doi_str_mv 10.1128/aac.26.4.580
facet_avail Online, Free
finc_class_facet Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMjYuNC41ODA
imprint American Society for Microbiology, 1984
imprint_str_mv American Society for Microbiology, 1984
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0066-4804, 1098-6596
issn_str_mv 0066-4804, 1098-6596
language English
last_indexed 2024-03-01T15:08:54.718Z
match_str aronoff1984comparativeactivitiesofthebetalactamaseinhibitorsytr830sodiumclavulanateandsulbactamcombinedwithamoxicillinorampicillin
mega_collection American Society for Microbiology (CrossRef)
physical 580-582
publishDate 1984
publishDateSort 1984
publisher American Society for Microbiology
record_format ai
recordtype ai
series Antimicrobial Agents and Chemotherapy
source_id 49
spelling Aronoff, S C Jacobs, M R Johenning, S Yamabe, S 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.26.4.580 <jats:p>YTR 830, a new beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam against aminopenicillin-resistant clinical isolates. At a concentration of 8 micrograms/ml, YTR 830 was as effective as clavulanate or sulbactam in reducing the aminopenicillin MICs. Combined with amoxicillin, YTR 830 is a potentially useful agent for therapy of many bacterial infections.</jats:p> Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin Antimicrobial Agents and Chemotherapy
spellingShingle Aronoff, S C, Jacobs, M R, Johenning, S, Yamabe, S, Antimicrobial Agents and Chemotherapy, Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin, Infectious Diseases, Pharmacology (medical), Pharmacology
title Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_full Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_fullStr Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_full_unstemmed Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_short Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_sort comparative activities of the beta-lactamase inhibitors ytr 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
title_unstemmed Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin
topic Infectious Diseases, Pharmacology (medical), Pharmacology
url http://dx.doi.org/10.1128/aac.26.4.580